Gabapentin Tablet, Coated
Product Images NDC 68094-069

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68094-069). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Precision Dose, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Gabapentin 01)

Chemical structure of gabapentin showing a cyclohexane ring bonded to an amino group (CH2NH2) and a carboxymethyl group (CH2CO2H).*

FDA Label Image

Figure 1 (Gabapentin 02)

A line graph showing mean pain scores over an 8-week period comparing Gabapentin 3,600 mg/day and placebo. The x-axis represents weeks from baseline to week 8, divided into a 4-week dose titration period and a 4-week fixed dose period. The y-axis shows mean pain scores from 0 to 10. Gabapentin shows a decreasing pain score trend while placebo remains relatively stable.*

FDA Label Image

Figure 2 (Gabapentin 03)

Line graph showing mean pain score over a 7-week period, comparing placebo and two gabapentin doses (1800 mg/day and 2400 mg/day). The timeline includes a 3-week dose titration period followed by a 4-week fixed dose period. The graph shows a greater reduction in pain scores for gabapentin doses compared to placebo.*

FDA Label Image

Figure 3 (Gabapentin 04)

A bar chart comparing two studies showing percentages for placebo (PBO) and Gabapentin (GBP) at different doses. Study 1 shows 12% for placebo and 29% for GBP 3,600 mg. Study 2 shows 14% for placebo, 32% for GBP 1,800 mg, and 34% for GBP 2,400 mg. Significance levels are indicated as p < 0.01 and p < 0.001.*

FDA Label Image

Figure 4 (Gabapentin 05)

A scatter plot comparing percentage difference versus daily dose (mg) for three studies labeled as study a, study b, and study c. Study a is represented by black squares, study b by gray squares, and study c by white squares, with data points showing dose-response relationships.*

FDA Label Image

Principal Display Panel (600 mg Tablet Blister Pack Carton Label)

Gabapentin 600 mg coated tablets unit dose packaging label by Precision Dose, Inc. The label indicates 100 tablets (10x10) with instructions for storage at 25°C (77°F) with permitted excursions. The label includes the NDC 68094-069-61 and warns to keep medication out of reach of children and to see the enclosed insert for usual dose.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.